Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06355791 · ClinicalTrials.gov registry record · NA

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

A NA study of Lumbar Spinal Stenosis and Spondylolisthesis, sponsored by Spinal Simplicity.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
6
Study locations

NCT06355791: Recruiting NA study of Lumbar Spinal Stenosis and Spondylolisthesis, sponsored by Spinal Simplicity.

NCT06355791 is a NA study of Lumbar Spinal Stenosis and Spondylolisthesis that is actively recruiting participants, run by Spinal Simplicity. The registered enrollment target is 150 participants, below the 661-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (77% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06355791, a NA study of Lumbar Spinal Stenosis and Spondylolisthesis, is actively recruiting participants, sponsored by Spinal Simplicity.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
6
Study locations

Study Summary

This is a prospective, multi-center open-label single arm post-market study where the purpose is to evaluate the effectiveness and safety of the market approved Spinal Simplicity Minuteman G5 MIS Fusion Plate and bone graft material in patients with degenerative conditions of the lumbar spine resulting in chronic low back pain with lower extremity symptoms and concurrent neurogenic claudication. The indication for the device under study is degenerative conditions of the lumbar spine resulting in back pain with lower extremity symptoms and neurogenic claudication.

Primary Outcome

Overall pain, as well as back pain when standing/walking and leg pain when standing will be assessed using a numeric rating scale (NRS). The NRS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable.

Interventions

  • DEVICE Minuteman G5 Device

Study Locations (6)

Georgia

  • Vista Clinical Research - Newnan

Indiana

  • Comprehensive Pain & Spine Specialists - Indianapolis

Kansas

  • University of Kansas Medical Center - Kansas City

Minnesota

  • Nura Precision Pain Management - Edina

Oregon

  • Pacific Sports & Spine - Eugene

West Virginia

  • Spine & Nerve Center of the Virginias - Charleston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-05-29
Est. Completion 2030-12
Phase NA
Spinal Simplicity

2 total trials

What NCT06355791 shows while recruiting

NCT06355791 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 661-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (77% lower).

The record links to 3 conditions, with Lumbar Spinal Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Minuteman G5 Device is the first listed.

NCT06355791 lists 6 locations in 6 states (Georgia, Indiana, Kansas).

Frequently Asked Questions

What is clinical trial NCT06355791 about?

NCT06355791 is a clinical study titled "Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device". This is a prospective, multi-center open-label single arm post-market study where the purpose is to evaluate the effectiveness and safety of the market approved Spinal Simplicity Minuteman G5 MIS Fusion Plate and bone graft material in patients with degenerative conditions of the lumbar spine result...

What is the current status of trial NCT06355791?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-05-29. Estimated completion is 2030-12.

What conditions does trial NCT06355791 study?

This clinical trial studies the following conditions: Lumbar Spinal Stenosis, Spondylolisthesis, Degenerative Conditions of the Lumbar Spine.

What interventions are being tested in trial NCT06355791?

The interventions under investigation include: Minuteman G5 Device (DEVICE).

Who is sponsoring clinical trial NCT06355791?

This trial is sponsored by Spinal Simplicity, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06355791 being conducted?

This trial has 6 study locations across Georgia, Indiana, Kansas, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lumbar Spinal Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06355791's enrollment target sits among peer trials

150 7th of 18 higher than 11 of 18 other Lumbar Spinal Stenosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lumbar Spinal Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06355791, the US trial registry maintained by the National Library of Medicine. NCT06355791 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.